Docusign (NASDAQ:DOCU) Announces Quarterly Earnings Results

Docusign (NASDAQ:DOCU) posted its quarterly earnings data on Thursday. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $1.09 by ($0.73), Zacks reports. Docusign had a return on equity of 17.48% and a net margin of 9.59%.

Docusign Stock Performance

NASDAQ DOCU traded up $0.58 during trading on Thursday, hitting $65.97. 5,274,905 shares of the company’s stock traded hands, compared to its average volume of 4,102,124. The stock has a market capitalization of $12.60 billion, a price-to-earnings ratio of 42.84, a PEG ratio of 2.27 and a beta of 0.90. Docusign has a 12-month low of $40.16 and a 12-month high of $86.65. The business has a 50 day moving average of $54.77 and a 200-day moving average of $49.59.

Insiders Place Their Bets

In related news, CEO Allan Thygesen sold 26,250 shares of Docusign stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $46.02, for a total value of $1,208,025.00. Following the completion of the transaction, the chief executive officer directly owned 159,038 shares in the company, valued at approximately $7,318,928.76. The trade was a 14.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 6,000 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total value of $273,240.00. Following the sale, the executive owned 89,972 shares in the company, valued at approximately $4,097,324.88. This represents a 6.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 90,965 shares of company stock worth $4,341,688 in the last three months. Insiders own 0.59% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Burton Enright Welch bought a new position in shares of Docusign in the 4th quarter worth $241,000. Vise Technologies Inc. raised its position in shares of Docusign by 12.6% during the 4th quarter. Vise Technologies Inc. now owns 3,501 shares of the company’s stock valued at $239,000 after buying an additional 393 shares in the last quarter. B. Riley Wealth Advisors Inc. bought a new stake in shares of Docusign during the 2nd quarter worth $210,000. iSAM Funds UK Ltd bought a new stake in shares of Docusign during the 3rd quarter worth $209,000. Finally, PharVision Advisers LLC purchased a new position in Docusign in the third quarter worth $206,000. Institutional investors own 77.64% of the company’s stock.

Key Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Raised outlook and AI demand: Docusign increased its fiscal 2027 guidance for revenue, annual recurring revenue (ARR), and Intelligent Agreement Management (IAM) as a percentage of total ARR. Management also cited stronger demand related to artificial intelligence, and raised its sales view for the second time this year. Docusign Announces Second Quarter Fiscal 2027 Financial Results
• Positive Sentiment: Higher analyst price target: BTIG Research raised its target for DOCU from $60 to $75 and reiterated a “buy” rating, signaling increased confidence in the company’s growth prospects. BTIG Research price target update
• Positive Sentiment: AI ecosystem expansion: BearingPoint integrated GenAIQ with Docusign’s Intelligent Agreement Management platform to help procurement teams identify hidden contract value. Docusign also integrated an AI tool with Google Cloud to streamline legal workflows, supporting the company’s strategy to expand beyond electronic signatures. BearingPoint integrates GenAIQ with Docusign
• Neutral Sentiment: Valuation and expectations: DOCU was trading well above its 200-day moving average ahead of earnings, indicating strong recent momentum but also elevated expectations for the results. Analysts broadly maintained a “hold” consensus, which may limit upside unless execution continues to improve. Docusign analyst consensus recommendation
• Negative Sentiment: Quarterly EPS miss: Docusign reported fiscal second-quarter earnings of $0.36 per share, below the $1.09 consensus estimate. The miss could weigh on the stock because it raises questions about near-term profitability, despite a reported 9.59% net margin and 17.48% return on equity.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on DOCU shares. Wall Street Zen lowered shares of Docusign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 2nd. Citizens Jmp reaffirmed a “market outperform” rating and issued a $86.00 price objective on shares of Docusign in a research report on Tuesday, August 18th. UBS Group set a $60.00 target price on shares of Docusign in a research note on Friday, June 5th. Weiss Ratings raised shares of Docusign from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 25th. Finally, Bank of America restated an “underperform” rating on shares of Docusign in a research note on Friday, August 28th. Four investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Docusign presently has an average rating of “Hold” and a consensus target price of $61.27.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.